Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santiago Madero

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Orbit (Amsterdam, Netherlands)|June 5, 2002
Eyelid molluscum contagiosum in patients with human immunodeficiency virus infectionEugenio Pérez-Blázquez, Inés Villafruela, Santiago Madero
The Lancet Regional Health. Europe|December 4, 2025
Current perspectives on psychedelic treatments in EuropeSantiago Madero, Oscar Soto-Angona, Genis Ona, et al.
Dialogues in Clinical Neuroscience|May 6, 2025
Psychedelic interventions for major depressive disorder in the elderly: Exploring novel therapies, promise and potentialIvona-Maria Tudorancea, Gabriela-Dumitrita Stanciu, Carla Torrent, et al.
Archives of Gynecology and Obstetrics|March 28, 2013
A local hemostatic agent for the management of postpartum hemorrhage due to placenta previa and placenta accreta: a cross-sectional studyDiego Portilla, Cristian Hernández-Giraldo, Bernardo Moreno, et al.
Pharmacopsychiatry|April 15, 2024
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum DisorderVicent Llorca-Bofí, Miquel Bioque, Santiago Madero, et al.
Antioxidants (Basel, Switzerland)|November 24, 2022
Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in SchizophreniaConstanza Morén, Nina Treder, Albert Martínez-Pinteño, et al.
International Journal of Molecular Sciences|February 11, 2023
Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell CulturesPatricia Gassó, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2024
Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophreniaDavid Olivares-Berjaga, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
International Journal of Molecular Sciences|January 21, 2023
The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of SchizophreniaNina Treder, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Neuroimage|December 8, 2022
Removing the effects of the site in brain imaging machine-learning - Measurement and extendable benchmarkAleix Solanes, Corentin J Gosling, Lydia Fortea, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Orbit (Amsterdam, Netherlands)|June 5, 2002
Eyelid molluscum contagiosum in patients with human immunodeficiency virus infectionEugenio Pérez-Blázquez, Inés Villafruela, Santiago Madero
The Lancet Regional Health. Europe|December 4, 2025
Current perspectives on psychedelic treatments in EuropeSantiago Madero, Oscar Soto-Angona, Genis Ona, et al.
Dialogues in Clinical Neuroscience|May 6, 2025
Psychedelic interventions for major depressive disorder in the elderly: Exploring novel therapies, promise and potentialIvona-Maria Tudorancea, Gabriela-Dumitrita Stanciu, Carla Torrent, et al.
Archives of Gynecology and Obstetrics|March 28, 2013
A local hemostatic agent for the management of postpartum hemorrhage due to placenta previa and placenta accreta: a cross-sectional studyDiego Portilla, Cristian Hernández-Giraldo, Bernardo Moreno, et al.
Pharmacopsychiatry|April 15, 2024
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum DisorderVicent Llorca-Bofí, Miquel Bioque, Santiago Madero, et al.
Antioxidants (Basel, Switzerland)|November 24, 2022
Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in SchizophreniaConstanza Morén, Nina Treder, Albert Martínez-Pinteño, et al.
International Journal of Molecular Sciences|February 11, 2023
Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell CulturesPatricia Gassó, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2024
Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophreniaDavid Olivares-Berjaga, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
International Journal of Molecular Sciences|January 21, 2023
The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of SchizophreniaNina Treder, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Neuroimage|December 8, 2022
Removing the effects of the site in brain imaging machine-learning - Measurement and extendable benchmarkAleix Solanes, Corentin J Gosling, Lydia Fortea, et al.
Pageof 3